Duchenne Muscular Dystrophy Drugs Market 2019 Duchenne Muscular Dystrophy Drugs Market | Page 6

PART 17: Key vendor analysis
BioMarin Pharmaceutical
Lilly
PTC Therapeutics
Santhera Pharmaceuticals
Sarepta Therapeutics
PART 18: Appendix
List of abbreviation
PART 19: Explore Technavio
Browse Full Report With TOC @ http://www.radiantinsights.com/research/global-duchennemuscular-dystrophy-drugs-market-2015-2019
List of Exhibits
Exhibit 01: Global Duchenne muscular dystrophy drugs market 2014-2019 ($ millions)
Exhibit 02: Five forces analysis
Exhibit 03: Heredogram of Duchenne muscular dystrophy
Exhibit 04: Biomarkers used in Duchenne muscular dystrophy
Exhibit 05: Various approaches to treating Duchenne muscular dystrophy
Exhibit 06: Percentage of Duchenne muscular dystrophy patients treated by exon skipping therapy
Exhibit 07: Prevalence of nonsense mutation Duchenne muscular dystrophy 2014
Exhibit 08: Global Duchenne muscular dystrophy drugs market segmentation by geography 2014
Exhibit 09: Duchenne muscular dystrophy: Pipeline portfolio
Exhibit 10: Impact of drivers
Exhibit 11: Impact of drivers and challenges
Exhibit 12: BioMarin Pharmaceutical: Key takeaways
Exhibit 13: Lilly: Key takeaways
Exhibit 14: PTC Therapeutics: Key takeaways